EGFR deletion in myeloid cells reprograms the immunosuppressive landscape of colorectal cancer
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research on colorectal cancer has identified a new mechanism involving the deletion of EGFR in myeloid cells, which appears to impact the immunosuppressive landscape of the disease. This finding may have implications for targeted therapy against metastasis. The study suggests that immune cells are playing a significant role in colorectal cancer, with further research emphasizing their importance.